503
Views
28
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD

, &
Pages 1111-1118 | Received 21 Apr 2014, Accepted 09 Jun 2014, Published online: 03 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hang Yin, Anhua Shi & Junzi Wu. (2022) Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 15, pages 2003-2030.
Read now
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren & Hanne Prytz. (2019) Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study. Scandinavian Journal of Gastroenterology 54:8, pages 1027-1032.
Read now
Erdim Sertoglu, Huseyin Kayadibi & Metin Uyanik. (2015) Some important points for the selection and exclusion of patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 50:2, pages 253-254.
Read now

Articles from other publishers (25)

Zaeem Sohail Jafar, Aniq Ahmed, Muhammad Nauman Akram, Muhammad Junaid Mirza & Khalida Ahtesham. (2023) FREQUENCY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS ASSOCIATION WITH DIABETES MELLITUS, HYPERTENSION AND CHOLELITHIASIS AMONG PATIENTS UNDERGOING ROUTINE ULTRASONOGRAPHY. JAIMC: Journal of Allama Iqbal Medical College 20:2.
Crossref
Rebecca L. Jensen, Robyn T. Kiy, Faten F. Bin Dayel & Amy E. Chadwick. 2023. Mitochondrial Intoxication. Mitochondrial Intoxication 77 100 .
Abdulrahman Ismaiel, Piero Portincasa & Dan L. Dumitrascu. 2023. Essentials of Non-Alcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease 19 43 .
Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, Victor Sapena, Nicola Colucci, Ferran Torres, Jordi Bruix, María Reig & Christian Toso. (2022) Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clinical Gastroenterology and Hepatology 20:2, pages 283-292.e10.
Crossref
Jie Chen, Alina M. Allen, Terry M. Therneau, Jun Chen, Jiahui Li, Safa Hoodeshenas, Jingbiao Chen, Xin Lu, Zheng Zhu, Sudhakar K. Venkatesh, Bin Song, Richard L. Ehman & Meng Yin. (2021) Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. European Radiology 32:2, pages 950-958.
Crossref
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2021) Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2021) Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis & Angela M Madden. (2018) Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Sang R. Lee, Sun Woo Kwon, Pelin Kaya, Young Ho Lee, Jong Geol Lee, Globinna Kim, Geun-Shik Lee, In-Jeoung Baek & Eui-Ju Hong. (2018) Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Scientific Reports 8:1.
Crossref
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis & Angela M Madden. (2018) Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Pegah Golabi, Maria Stepanova, Huong T Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll & Zobair M Younossi. (2018) Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterology 5:1, pages e000198.
Crossref
Christina C. Lindenmeyer & Arthur J. McCullough. (2018) The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View. Clinics in Liver Disease 22:1, pages 11-21.
Crossref
Varun Saxena & Norah A. Terrault. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 784 815.e14 .
Ignazio Barbagallo, Giovanni Li Volti, Marco Raffaele, Alfio Distefano, Rosa Palmeri, Lucia Parafati, Maria Licari, Veronica Zingales, Roberto Avola & Luca Vanella. (2017) The effects of olive leaf extract from a Sicilian cultivar in an experimental model of hepatic steatosis. Rendiconti Lincei 28:4, pages 643-650.
Crossref
Marek Hartleb, Kamil Barański, Jan Zejda, Jerzy Chudek & Andrzej Więcek. (2017) Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey. Liver International 37:11, pages 1706-1714.
Crossref
Luca Miele, Teresa De Michele, Giuseppe Marrone, Maria Antonietta Isgrò, Umberto Basile, Consuelo Cefalo, Marco Biolato, Fabio Maria Vecchio, Gian Lodovico Rapaccini, Antonio Gasbarrini, Cecilia Zuppi & Antonio Grieco. (2017) Enhanced Liver Fibrosis Test as a Reliable Tool for Assessing Fibrosis in Nonalcoholic Fatty Liver Disease in a Clinical Setting. The International Journal of Biological Markers 32:4, pages 397-402.
Crossref
Rosa Lombardi, Simona Onali, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy & Emmanuel Tsochatzis. (2017) Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD). Cochrane Database of Systematic Reviews 2017:4.
Crossref
Yan Li, Weizhong Zhang, Anne Doughtie, Guozhen Cui, Xuanyi Li, Harshul Pandit, Yingbin Yang, Suping Li & Robert Martin. (2016) Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Oncotarget 7:32, pages 52329-52339.
Crossref
Tuan Pham, Travis B. Dick & Michael R. Charlton. (2016) Nonalcoholic Fatty Liver Disease and Liver Transplantation. Clinics in Liver Disease 20:2, pages 403-417.
Crossref
George Boon-Bee Goh & Arthur J. McCullough. (2016) Natural History of Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 61:5, pages 1226-1233.
Crossref
MOHAMMAD J. ALKHATATBEH, LISA F. LINCZ & RICK F. THORNE. (2016) Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine 11:4, pages 1487-1492.
Crossref
Metin Basaranoglu, Sonia M Najjar, Ali Ebag Demirbag & Hakan Senturk. (2016) Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World Journal of Hepatology 8:7, pages 376.
Crossref
Liat Mlynarsky, Dalit Schlesinger, Roni Lotan, Muriel Webb, Zamir Halpern, Erwin Santo, Oren Shibolet & Shira Zelber-Sagi. (2016) Non-alcoholic fatty liver disease is not associated with a lower health perception. World Journal of Gastroenterology 22:17, pages 4362.
Crossref
Fabio Nascimbeni & Vlad Ratziu. 2016. Alcoholic and Non-Alcoholic Fatty Liver Disease. Alcoholic and Non-Alcoholic Fatty Liver Disease 271 290 .
Kurinchi Selvan Gurusamy, Douglas Thorburn, Brian R Davidson & Emmanuel Tsochatzis. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.